Apyx Medical (APYX) Income from Continuing Operations (2011 - 2026)
Apyx Medical (APYX) posted Income from Continuing Operations of 2143000.0 for Q1 2026, up 49.69% on a QoQ basis from 4260000.0 in Q4 2025, and up 48.63% year-over-year from 1441799.06 in Q1 2025.
Apyx Medical (APYX) Income from Continuing Operations (2011 - 2026) Analysis & Trends
Apyx Medical's Income from Continuing Operations history runs 16 years deep, the most recent figure standing at 2143000.0 for Q1 2026.
- Quarterly Income from Continuing Operations rose 48.63% year-over-year to 2143000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 12096000.0 (up 45.91% YoY) and the FY2025 annual result came in at 14125000.0, up 45.21% from the prior year.
- Income from Continuing Operations was 2143000.0 for Q1 2026 at Apyx Medical, up from 4260000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 1019000.0 in Q2 2023 and bottomed at 9624000.0 in Q4 2023.
- A 5-year average of 4951588.24 and a median of 4724000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations jumped 81.3% — and 2024, when it plunged 546.32%.
- Apyx Medical's Income from Continuing Operations stood at 6065000.0 in 2022, then tumbled by 58.68% to 9624000.0 in 2023, then grew by 28.5% to 6881000.0 in 2024, then soared by 38.09% to 4260000.0 in 2025, then surged by 49.69% to 2143000.0 in 2026.
- Business Quant data shows APYX's Income from Continuing Operations at 2143000.0 in Q1 2026, 4260000.0 in Q4 2025, and 1955000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | 380.70 Mn |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 199.50 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | 273.95 Mn |
| 10 | Apyx Medical | 168.63 Mn | 137.49 Mn | 7.93 Mn | -2.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.14 Mn |
| Dec 31, 2025 | -4.26 Mn |
| Sep 30, 2025 | -1.96 Mn |
| Jun 30, 2025 | -3.74 Mn |
| Mar 31, 2025 | -4.17 Mn |
| Dec 31, 2024 | -6.88 Mn |
| Sep 30, 2024 | -4.72 Mn |
| Jun 30, 2024 | -6.59 Mn |
| Mar 31, 2024 | -7.59 Mn |
| Dec 31, 2023 | -9.62 Mn |
| Sep 30, 2023 | -4.68 Mn |
| Jun 30, 2023 | -1.02 Mn |
| Mar 31, 2023 | -3.53 Mn |
| Dec 31, 2022 | -6.07 Mn |
| Sep 30, 2022 | -5.80 Mn |
| Jun 30, 2022 | -5.45 Mn |
| Mar 31, 2022 | -5.97 Mn |
| Dec 31, 2021 | -2.01 Mn |
| Sep 30, 2021 | -4.23 Mn |
| Jun 30, 2021 | -4.05 Mn |